Dr. Bob Lebovics US Inactive
LEBOVICS FOR SENATE
Dr. Bob Lebovics
Dr. Bob is a nationally renowned otolaryngologist and ENT surgeon who specializes in infectious and inflammatory disorders. In other words, he helps people breathe and helps them live a better life. That’s exactly why he’s running for U.S. Senate.
Ad copy
Nationally renowned ENT surgeon and America-first conservative running to represent New Jersey in the U.S Senate.
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 42.2/100 |
| Spend / Reach / Long. / Eff. | 34.7 · 70.7 · 1.7 · 61.5 |
| Spend range | USD 1,000–1,499 |
| Impressions | 50,000 – 59,999 |
| CPM (≈ $/1k impr) | USD 22.72 |
| Est. audience size | 50,001 – 100,000 |
| Days live | 7 (2026-05-19 → 2026-05-26) |
| Created | 2026-05-19 |
| Creative variants | 1 body · 1 headline |
| Platforms | facebook, instagram |
| Languages | en |
| Candidate | NJ — Bob Lebovics |
| Surfaced by | “senate:Bob Lebovics” |
🧠 AI analysis
| Issue | candidate character bio |
| Framing | positive candidate |
| Message type | gotv mobilization |
| Emotional appeal | pride |
| Production tier | semi pro |
| Who pictured | candidate |
| Symbols | us flag |
| Call to action | vote |
| Standout element | Bold red-white-blue gradient with oversized 'JUNE 2ND' deadline creating urgent call to action |
| Tactic | Combines professional credentials (ENT surgeon) with America-first identity branding to build authoritative trust while driving urgency around a specific primary election date. |
Where it ran (delivery by region)
| New Jersey | 89.3% |
| Florida | 1.9% |
| Pennsylvania | 1.6% |
| New York | 1.6% |
| California | 0.6% |
| South Carolina | 0.5% |
| North Carolina | 0.5% |
Who saw it (delivery)
| 18-24 · female | 1.5% |
| 45-54 · male | 4.6% |
| 65+ · male | 22.2% |
| 65+ · female | 30.7% |
| 55-64 · unknown | 0.1% |
| 55-64 · male | 9.3% |
| 55-64 · female | 9.1% |
| 45-54 · unknown | 0.0% |
| 45-54 · female | 3.7% |
| 18-24 · male | 2.0% |
| 35-44 · unknown | 0.0% |
| 35-44 · male | 4.7% |
| 35-44 · female | 2.9% |
| 25-34 · unknown | 0.1% |
| 25-34 · male | 5.7% |
| 25-34 · female | 2.9% |
| 18-24 · unknown | 0.0% |
| 65+ · unknown | 0.4% |
